• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Seattle Genetics Inc

+ Add to Watchlist

SGT:GR

32.190 EUR 0.171 0.53%

As of 02:08:47 ET on 08/20/2014.

Snapshot for Seattle Genetics Inc (SGT)

Open: 31.895 Day's Range: 31.895 - 32.190 Volume: 0
Previous Close: 32.019 52wk Range: 23.785 - 40.070 1-Yr Rtn: +5.88%

Stock Chart for SGT

No chart data available.
  • SGT:GR 31.895
  • 1D
  • 1M
  • 1Y
32.019
Interactive SGT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SGT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.8040
Est. PEG Ratio -
Market Cap (M EUR) 3,973.79
Shares Outstanding (M) 123.45
30 Day Average Volume 90
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SGT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SGT

Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company's technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer.

Clay B SiegallChairman/Pres/CEO/Co-FounderTodd E SimpsonChief Financial Officer
Eric L DobmeierCOO/SecretaryJonathan DrachmanExec VP:Research & Dev
More Company Profile & Key Executives for SGT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil